\-\ Texto\\:\\ \ \(0\)\
\-\ \\>\\>physical\\ exam\\ within\\ normal\\ limits\\.\\ no\\ evidence\\ of\\ sonographic\\ murphy\\'s\\ sign\\.\ \(0\)\
\-\ \\>\\>normal\\ liver\\ function\\ tests\\.\ \(0\)\
\-\ treatment\\ is\\ generally\\ conservative\\,\\ if\\ the\\ patient\\ is\\ symptomatic\\.\ \(0\)\
\-\ \\>\\>intramural\\ cystic\\ formation\\ \\(anechoic\\ diverticula\\)\\ with\\ echogenic\\ foci\\ \ \(0\)\
\-\ \\>\\>comet\\-tail\\/ring\\-down\\ reverberation\\ artifacts\\ together\\ \ \(0\)\
\-\ with\\ segmental\\/partial\\ thickening\\ of\\ the\\ gallbladder\\ wall\\ are\\ considered\\ to\\ be\\ the\\ diagnostic\\ findings\\ on\\ us\\ examination\\.\ \(0\)\
\-\ comet\\ tail\\ artifacts\\ are\\ generally\\ v\\-shaped\\ and\\ short\\.\ \(0\)\
\-\ adenomyomatosis\ \(9\)\
\-\ differential\\ for\\ focal\\ gallbladder\\ wall\\ thickening\\ or\\ intraluminal\\ polypoid\\ masses\\:\ \(0\)\
\-\ 1\\.\\ \\ adenomyomatosis\ \(0\)\
\-\ 2\\.\\ \\ adenomatous\\,\\ hyperplastic\\,\\ and\\ cholesterol\\ polyps\ \(0\)\
\-\ 3\\.\\ \\ gall\\ bladder\\ carcinoma\ \(0\)\
\-\ 4\\.\\ \\ carcinoid\\ tumor\ \(0\)\
\-\ 5\\.\\ \\ metastatic\\ disease\\ \\(e\\.g\\.\\,\\ melanoma\\)\ \(0\)\
\-\ 6\\.\\ \\ hematoma\\ \ \(0\)\
\-\ ref\\:\\ dogra\\ vs\\,\\ adenomyomatosis\\.\\ \\ emedicine\\.com\ \(0\)\
\-\ 68\\ year\\ old\\ male\\ with\\ possible\\ pericholecsytic\\ fluid\\ noted\\ on\\ previous\\ ct\\ scan\\ of\\ the\\ abdomen\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adenomyomatosis\\:\\ 0\\.3835568152338573\ \(0\)\
\-\ artifacts\\:\\ 0\\.2714471643317974\ \(0\)\
\-\ comet\\:\\ 0\\.26429721300614695\ \(0\)\
\-\ tail\\:\\ 0\\.20045633697414947\ \(0\)\
\-\ gallbladder\\:\\ 0\\.18161347716136647\ \(0\)\
\-\ generally\\:\\ 0\\.17216761608463096\ \(0\)\
\-\ pericholecsytic\\:\\ 0\\.1625189250339603\ \(0\)\
\-\ reverberation\\:\\ 0\\.15529550912725215\ \(0\)\
\-\ dogra\\:\\ 0\\.15529550912725215\ \(0\)\
\-\ thickening\\:\\ 0\\.13827298172111757\ \(0\)\
\-\ ref\\:\\ 0\\.12439335600797392\ \(0\)\
\-\ wall\\:\\ 0\\.12363812693141758\ \(0\)\
\-\ hyperplastic\\:\\ 0\\.12241185622951559\ \(0\)\
\-\ polypoid\\:\\ 0\\.11980009544842818\ \(0\)\
\-\ adenomatous\\:\\ 0\\.11752272659298944\ \(0\)\
\-\ gall\\:\\ 0\\.11615165520454526\ \(0\)\
\-\ together\\:\\ 0\\.11487860406701603\ \(0\)\
\-\ intramural\\:\\ 0\\.11312488081537914\ \(0\)\
\-\ cholesterol\\:\\ 0\\.11257667954172003\ \(0\)\
\-\ murphy\\:\\ 0\\.11102656005660813\ \(0\)\
\-\ anechoic\\:\\ 0\\.11102656005660813\ \(0\)\
\-\ diverticula\\:\\ 0\\.11006334517487029\ \(0\)\
\-\ polyps\\:\\ 0\\.10960058836073835\ \(0\)\
\-\ carcinoid\\:\\ 0\\.10705122741809062\ \(0\)\
\-\ intraluminal\\:\\ 0\\.10380314414989998\ \(0\)\
\-\ 68\\:\\ 0\\.09771483412022501\ \(0\)\
\-\ tests\\:\\ 0\\.09725207730609309\ \(0\)\
\-\ melanoma\\:\\ 0\\.09490177022938094\ \(0\)\
\-\ echogenic\\:\\ 0\\.09318561845527791\ \(0\)\
\-\ sonographic\\:\\ 0\\.09145463309525469\ \(0\)\
\-\ short\\:\\ 0\\.08734782284403805\ \(0\)\
\-\ foci\\:\\ 0\\.08306084723245558\ \(0\)\
\-\ normal\\:\\ 0\\.082984808548645\ \(0\)\
\-\ function\\:\\ 0\\.08225550624382261\ \(0\)\
\-\ the\\:\\ 0\\.08111069393722856\ \(0\)\
\-\ us\\:\\ 0\\.08083710740063262\ \(0\)\
\-\ formation\\:\\ 0\\.08056649254164594\ \(0\)\
\-\ limits\\:\\ 0\\.08029992693503354\ \(0\)\
\-\ considered\\:\\ 0\\.07918879103192654\ \(0\)\
\-\ bladder\\:\\ 0\\.07886039213560735\ \(0\)\
\-\ conservative\\:\\ 0\\.07845822752603794\ \(0\)\
\-\ symptomatic\\:\\ 0\\.07814290715887157\ \(0\)\
\-\ vs\\:\\ 0\\.07752853125373803\ \(0\)\
\-\ diagnostic\\:\\ 0\\.07745320287232703\ \(0\)\
\-\ are\\:\\ 0\\.07712338440123656\ \(0\)\
\-\ previous\\:\\ 0\\.07678920791774341\ \(0\)\
\-\ hematoma\\:\\ 0\\.07112908350093275\ \(0\)\
\-\ sign\\:\\ 0\\.07035551180400657\ \(0\)\
\-\ liver\\:\\ 0\\.0701049431774838\ \(0\)\
\-\ masses\\:\\ 0\\.06918368330050226\ \(0\)\
\-\ possible\\:\\ 0\\.06885593174473512\ \(0\)\
\-\ differential\\:\\ 0\\.06603036161563727\ \(0\)\
\-\ examination\\:\\ 0\\.06502968060934215\ \(0\)\
\-\ abdomen\\:\\ 0\\.062007585179010775\ \(0\)\
\-\ on\\:\\ 0\\.06138439429912191\ \(0\)\
\-\ cystic\\:\\ 0\\.06120468756057525\ \(0\)\
\-\ focal\\:\\ 0\\.06078689303776241\ \(0\)\
\-\ carcinoma\\:\\ 0\\.06078689303776241\ \(0\)\
\-\ scan\\:\\ 0\\.06029240038380237\ \(0\)\
\-\ with\\:\\ 0\\.05969775840264168\ \(0\)\
\-\ of\\:\\ 0\\.059662110305950575\ \(0\)\
\-\ if\\:\\ 0\\.05904607863712522\ \(0\)\
\-\ fluid\\:\\ 0\\.05867546809622998\ \(0\)\
\-\ evidence\\:\\ 0\\.05768194364221786\ \(0\)\
\-\ metastatic\\:\\ 0\\.05573568906029615\ \(0\)\
\-\ is\\:\\ 0\\.05566085437602996\ \(0\)\
\-\ physical\\:\\ 0\\.055102874295252124\ \(0\)\
\-\ noted\\:\\ 0\\.05388090442692759\ \(0\)\
\-\ tumor\\:\\ 0\\.05315525648908517\ \(0\)\
\-\ exam\\:\\ 0\\.05115758043288105\ \(0\)\
\-\ findings\\:\\ 0\\.050155528007134055\ \(0\)\
\-\ treatment\\:\\ 0\\.048408911115087994\ \(0\)\
\-\ within\\:\\ 0\\.046804888001375965\ \(0\)\
\-\ male\\:\\ 0\\.04524692117953419\ \(0\)\
\-\ disease\\:\\ 0\\.04265815165306123\ \(0\)\
\-\ and\\:\\ 0\\.041998717414211906\ \(0\)\
\-\ be\\:\\ 0\\.04122480054293577\ \(0\)\
\-\ ct\\:\\ 0\\.03868921698037328\ \(0\)\
\-\ or\\:\\ 0\\.03535318557505316\ \(0\)\
\-\ patient\\:\\ 0\\.033053190730656726\ \(0\)\
\-\ no\\:\\ 0\\.03304697361816617\ \(0\)\
\-\ year\\:\\ 0\\.03131852089392512\ \(0\)\
\-\ for\\:\\ 0\\.030801459286966034\ \(0\)\
\-\ old\\:\\ 0\\.03007662123321638\ \(0\)\
\-\ to\\:\\ 0\\.025405804354439728\ \(0\)\
